Starpharma Holdings (ASX: SPL) Share Price

SPL

$0.68▲+1.49%

$286.2MRank #581 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$286.2M

Volume

344K

P/E Ratio

27.58

EPS

$0.0033

Dividend Yield

0.00%

52-Week High

$0.79

52-Week Low

$0.082

Beta

0.769

Starpharma Holdings (ASX: SPL) is an Australian-listed company in the Healthcare sector with a market capitalisation of $286.2M and the 581st-largest security on the ASX by market capitalisation. The SPL share price is $0.68, up 1.49% today and up 655.56% over the past 12 months. Shares have traded between $0.082 and $0.79 over the past 52 weeks. SPL trades on a price-to-earnings ratio of 27.58, above the Healthcare sector median of 14.96. In its most recent reported period (ending 31 Dec 2025), Starpharma Holdings reported revenue of $10.8M and a net profit of $1.4M (12.6% margin).

Charts

$0.68

24H Range

$0.67

$0.695

52-Week Range

$0.082

$0.79

About Starpharma Holdings Limited

Starpharma Holdings Limited is a biopharmaceutical enterprise focused on the research, development, and global commercialization of dendrimer-based products for the pharmaceutical, life sciences, and other industries. Its current offerings include VivaGel, a non-antibiotic treatment and preventative measure for bacterial vaginosis. The company also provides the antiviral VivaGel condom and VIRALEZE, an antiviral nasal spray. Furthermore, Starpharma is actively progressing its DEP (dendrimer drug delivery) technology platform. This platform supports multiple oncology candidates in clinical development, such as DEP docetaxel (Phase 2), DEP cabazitaxel (Phase 2), DEP gemcitabine (Phase 1/2), and DEP irinotecan (Phase 2), all aimed at treating cancer. The DEP technology is also being applied to radiotheranostics for cancer diagnosis and therapy, Antibody Drug Conjugates (including DEP HER-2 ADC), and non-oncology programs. Additionally, DEP AZD0466 is currently in Phase 1/2 clinical trials for haematological malignancies. Founded in 1996, the company maintains its headquarters in Abbotsford, Australia.

IPO Date

27 Sept 2000

CEO

Cheryl Maley

Employees

Website

starpharma.com

Key Financial Data

Revenue (Quarterly)	$10.8M
Net Income (Quarterly)	$1.4M
Total Assets	$26.2M
Total Debt	$790,000
Free Cash Flow	$3.7M
Return on Equity	6.36%
Profit Margin	12.62%
Operating Margin	-36.10%

SPL Frequently Asked Questions

What is the Starpharma Holdings (ASX: SPL) share price?

The SPL share price is $0.68, up 1.49% for the day, based on the latest available ASX market data.

What is Starpharma Holdings's market capitalisation?

Starpharma Holdings has a market capitalisation of $286.2M, making it the 581st-largest security listed on the ASX.

Does Starpharma Holdings pay a dividend?

SPL does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

What is SPL's P/E ratio?

Starpharma Holdings trades on a trailing price-to-earnings (P/E) ratio of 27.58, based on its current share price and most recent reported earnings.

Is Starpharma Holdings profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), SPL reported revenue of $10.8M and a net profit of $1.4M.

How many SPL shares are on issue?

Starpharma Holdings has approximately 420,928,000 shares on issue, based on its market capitalisation of $286.2M and current share price.

What sector is Starpharma Holdings in?

Starpharma Holdings is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Starpharma Holdings list on the ASX?

Starpharma Holdings listed on the Australian Securities Exchange on 27 Sept 2000.

Latest News

Loss-Making Starpharma Holdings Limited (ASX:SPL) Expected To Breakeven In The Medium-Term

Yahoo Finance18 May 2026

Loss-Making Starpharma Holdings Limited (ASX:SPL) Expected To Breakeven In The Medium-Term Yahoo Finance

Starpharma (ASX:SPL) Jumps Over 580% in a Year: What’s Behind the Rally?

Kalkine16 Apr 2026

Starpharma (ASX:SPL) Jumps Over 580% in a Year: What’s Behind the Rally? Kalkine

Starpharma Holdings Insider Confidence Rewarded, Stock Hits AU$166m Market Cap

simplywall.st29 Jan 2026

Starpharma Holdings Insider Confidence Rewarded, Stock Hits AU$166m Market Cap simplywall.st

This ASX biotech's shares just hit a new 12-month high, up more than 700% over a year. Here's why

The Motley Fool Australia21 Apr 2026

This ASX biotech's shares just hit a new 12-month high, up more than 700% over a year. Here's why The Motley Fool Australia

Insights: Starpharma Holdings Ltd (ASX:SPL)

smallcaps.com.au30 Oct 2025

Insights: Starpharma Holdings Ltd (ASX:SPL) smallcaps.com.au

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
ONEOneview Healthcare PLC	$149.6M	$0.17	-9.06	0.00%	▲+4.62%
EMVEMVision Medical Devices Ltd	$145.9M	$1.57	-10.00	0.00%	▼-1.88%
RCERecce Pharmaceuticals Ltd	$144.6M	$0.50	-2.84	0.00%	▲+2.04%
ACWActinogen Medical Limited	$122.0M	$0.034	-4.28	0.00%	–+0.00%
ATHAlterity Therapeutics Limited	$107.7M	$0.495	-2.12	0.00%	▲+11.24%
ILAIsland Pharmaceuticals Limited	$95.0M	$0.38	-5.66	0.00%	▲+7.04%
NYRNyrada Inc.	$87.9M	$0.44	-20.63	0.00%	▼-2.22%
ALAArovella Therapeutics Limited	$81.0M	$0.067	-14.80	0.00%	▲+1.52%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.67	$0.695	$0.67	$0.68	288K	▲+1.49%
11 June 2026	$0.70	$0.70	$0.66	$0.67	384K	▼-2.90%
10 June 2026	$0.695	$0.705	$0.66	$0.69	894K	▼-0.29%
9 June 2026	$0.75	$0.75	$0.685	$0.692	1.2M	▼-8.34%
8 June 2026	$0.76	$0.767	$0.74	$0.755	1.6M	▼-0.26%
5 June 2026	$0.76	$0.767	$0.74	$0.757	1.3M	▲+0.93%
4 June 2026	$0.755	$0.76	$0.735	$0.75	280K	–+0.00%
3 June 2026	$0.755	$0.76	$0.73	$0.75	2.6M	▲+0.40%
2 June 2026	$0.715	$0.76	$0.685	$0.747	1.7M	▲+3.03%
1 June 2026	$0.70	$0.725	$0.69	$0.725	797K	▲+4.32%
29 May 2026	$0.69	$0.705	$0.685	$0.695	513K	▲+3.73%
28 May 2026	$0.67	$0.67	$0.65	$0.67	599K	–+0.00%
27 May 2026	$0.68	$0.70	$0.66	$0.67	510K	–+0.00%
26 May 2026	$0.67	$0.69	$0.65	$0.67	1.7M	▲+4.69%
25 May 2026	$0.61	$0.655	$0.61	$0.64	383K	▲+4.07%
22 May 2026	$0.62	$0.63	$0.60	$0.615	457K	▼-0.32%
21 May 2026	$0.605	$0.635	$0.59	$0.617	1.4M	▲+1.98%
20 May 2026	$0.59	$0.61	$0.585	$0.605	2.2M	▲+1.68%
19 May 2026	$0.58	$0.595	$0.535	$0.595	3.9M	▲+9.17%
18 May 2026	$0.60	$0.615	$0.54	$0.545	3.7M	▼-12.10%
15 May 2026	$0.625	$0.65	$0.58	$0.62	1.8M	▼-4.62%
14 May 2026	$0.73	$0.732	$0.645	$0.65	2M	▼-10.96%
13 May 2026	$0.725	$0.75	$0.72	$0.73	543K	▼-2.01%
12 May 2026	$0.735	$0.79	$0.72	$0.745	2.9M	▲+1.36%
11 May 2026	$0.725	$0.74	$0.69	$0.735	1.5M	▲+1.38%
8 May 2026	$0.73	$0.73	$0.715	$0.725	480K	▼-1.36%
7 May 2026	$0.74	$0.76	$0.717	$0.735	2.1M	▲+0.68%
6 May 2026	$0.73	$0.75	$0.72	$0.73	595K	▲+0.69%
5 May 2026	$0.72	$0.74	$0.70	$0.725	998K	▼-2.68%
4 May 2026	$0.71	$0.745	$0.71	$0.745	1M	▲+4.20%

About Starpharma Holdings Limited

IPO Date

27 Sept 2000

CEO

Cheryl Maley

Employees

Website

starpharma.com

SPL Frequently Asked Questions

What is the Starpharma Holdings (ASX: SPL) share price?

The SPL share price is $0.68, up 1.49% for the day, based on the latest available ASX market data.

What is Starpharma Holdings's market capitalisation?

Starpharma Holdings has a market capitalisation of $286.2M, making it the 581st-largest security listed on the ASX.

Does Starpharma Holdings pay a dividend?

SPL does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

What is SPL's P/E ratio?

Starpharma Holdings trades on a trailing price-to-earnings (P/E) ratio of 27.58, based on its current share price and most recent reported earnings.

Is Starpharma Holdings profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), SPL reported revenue of $10.8M and a net profit of $1.4M.

How many SPL shares are on issue?

Starpharma Holdings has approximately 420,928,000 shares on issue, based on its market capitalisation of $286.2M and current share price.

What sector is Starpharma Holdings in?

Starpharma Holdings is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Starpharma Holdings list on the ASX?

Starpharma Holdings listed on the Australian Securities Exchange on 27 Sept 2000.

Company

Market Cap

Price

P/E

Div Yield

1D Change

ONEOneview Healthcare PLC

$149.6M

$0.17

-9.06

0.00%

▲+4.62%

EMVEMVision Medical Devices Ltd

$145.9M

$1.57

-10.00

0.00%

▼-1.88%

RCERecce Pharmaceuticals Ltd

$144.6M

$0.50

-2.84

0.00%

▲+2.04%

ACWActinogen Medical Limited

$122.0M

$0.034

-4.28

0.00%

–+0.00%

ATHAlterity Therapeutics Limited

$107.7M

$0.495

-2.12

0.00%

▲+11.24%

ILAIsland Pharmaceuticals Limited

$95.0M

$0.38

-5.66

0.00%

▲+7.04%

NYRNyrada Inc.

$87.9M

$0.44

-20.63

0.00%

▼-2.22%

ALAArovella Therapeutics Limited

$81.0M

$0.067

-14.80

0.00%

▲+1.52%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.67	$0.695	$0.67	$0.68	288K	▲+1.49%
11 June 2026	$0.70	$0.70	$0.66	$0.67	384K	▼-2.90%
10 June 2026	$0.695	$0.705	$0.66	$0.69	894K	▼-0.29%
9 June 2026	$0.75	$0.75	$0.685	$0.692	1.2M	▼-8.34%
8 June 2026	$0.76	$0.767	$0.74	$0.755	1.6M	▼-0.26%
5 June 2026	$0.76	$0.767	$0.74	$0.757	1.3M	▲+0.93%
4 June 2026	$0.755	$0.76	$0.735	$0.75	280K	–+0.00%
3 June 2026	$0.755	$0.76	$0.73	$0.75	2.6M	▲+0.40%
2 June 2026	$0.715	$0.76	$0.685	$0.747	1.7M	▲+3.03%
1 June 2026	$0.70	$0.725	$0.69	$0.725	797K	▲+4.32%
29 May 2026	$0.69	$0.705	$0.685	$0.695	513K	▲+3.73%
28 May 2026	$0.67	$0.67	$0.65	$0.67	599K	–+0.00%
27 May 2026	$0.68	$0.70	$0.66	$0.67	510K	–+0.00%
26 May 2026	$0.67	$0.69	$0.65	$0.67	1.7M	▲+4.69%
25 May 2026	$0.61	$0.655	$0.61	$0.64	383K	▲+4.07%
22 May 2026	$0.62	$0.63	$0.60	$0.615	457K	▼-0.32%
21 May 2026	$0.605	$0.635	$0.59	$0.617	1.4M	▲+1.98%
20 May 2026	$0.59	$0.61	$0.585	$0.605	2.2M	▲+1.68%
19 May 2026	$0.58	$0.595	$0.535	$0.595	3.9M	▲+9.17%
18 May 2026	$0.60	$0.615	$0.54	$0.545	3.7M	▼-12.10%
15 May 2026	$0.625	$0.65	$0.58	$0.62	1.8M	▼-4.62%
14 May 2026	$0.73	$0.732	$0.645	$0.65	2M	▼-10.96%
13 May 2026	$0.725	$0.75	$0.72	$0.73	543K	▼-2.01%
12 May 2026	$0.735	$0.79	$0.72	$0.745	2.9M	▲+1.36%
11 May 2026	$0.725	$0.74	$0.69	$0.735	1.5M	▲+1.38%
8 May 2026	$0.73	$0.73	$0.715	$0.725	480K	▼-1.36%
7 May 2026	$0.74	$0.76	$0.717	$0.735	2.1M	▲+0.68%
6 May 2026	$0.73	$0.75	$0.72	$0.73	595K	▲+0.69%
5 May 2026	$0.72	$0.74	$0.70	$0.725	998K	▼-2.68%
4 May 2026	$0.71	$0.745	$0.71	$0.745	1M	▲+4.20%